Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function

被引:36
作者
Braaksma, MMJ
Wijers, OB
de Koste, JRV
van der Est, H
Schmitz, PIM
Nowak, PJCM
Levendag, PC
机构
[1] Erasmus Med Ctr Daniel den Hoed, Dept Radiat Oncol, NL-3075 EA Rotterdam, Netherlands
[2] Erasmus Med Ctr Daniel den Hoed, Dept Med Stat, NL-3075 EA Rotterdam, Netherlands
关键词
laryngeal carcinoma; conformal radiation therapy; intensity modulated radiation therapy; salivary gland sparing; whole saliva; xerostomia;
D O I
10.1016/S0167-8140(03)00038-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Prevention of damage to critical normal tissues is of paramount importance for the quality of life of patients irradiated for cancers in the head and neck. The purpose of this paper was to evaluate the parotid gland sparing 3D conformal radiation therapy technique (3DCRT) in a prospective study in node negative cancer of the larynx. Materials and methods: Twenty-six patients with node negative squamous cell cancer of the larynx were irradiated by a 3DCRT technique (class solution) to both sides of the neck (elective dose 46 Gy to levels II, III and IV) and primary tumour (70 Gy). Dose distributions of the major salivary glands were correlated with objective (stimulated whole saliva flow, WS) and subjective (questionnaire; visual analogue scale, VAS) salivary gland function. Apart from the clinically used 3DCRT technique, in order to optimise 3DCRT dose distributions, intensity modulated (IMRT) treatment plans were generated for the same patient population. Dose-volume histograms of 3DCRT and IMRT treatment plans were analysed and compared. Results: For the 26 patients irradiated with the 3DCRT class solution technique: VAS scores and questionnaires reached their nadir 3 months post-radiotherapy; WS reached its nadir 6 months post-radiotherapy. WS flow rates improved significantly, but never normalised; 2 years post-treatment WS measurements were 48% of the pre-treatment values. VAS scores deteriorated during ERT from 0 pre-treatment to 6.1 immediately post-treatment. Compared to pre-treatment, questionnaires were answered affirmative by increasing numbers of patients. For all patients, IMRT treatment plans resulted in a significant reduction of the dose delivered to the parotid glands compared to the 3DCRT-treatment technique. Conclusions: The class solution for the 3DCRT salivary gland sparing technique is inadequate for fully preserving salivary gland function, given the dose distributions (DVHs) as well as the subjective- and objective salivary gland function assessments. The results can be optimised in the future, that is a further reduction of xerostomia can be achieved, by using IMRT techniques focused at sparing major and minor salivary glands. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 75 条
[61]   MEASUREMENTS OF HUMAN MINOR SALIVARY-GLAND SECRETIONS FROM DIFFERENT ORAL SITES [J].
SIVARAJASINGAM, V ;
DRUMMOND, JR .
ARCHIVES OF ORAL BIOLOGY, 1995, 40 (08) :723-729
[62]   Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity [J].
Skladowski, K ;
Maciejewski, B ;
Golen, M ;
Pilecki, B ;
Przeorek, W ;
Tarnawski, R .
RADIOTHERAPY AND ONCOLOGY, 2000, 55 (02) :101-110
[63]   TUMOR RESPONSE, TOXICITY, AND SURVIVAL AFTER NEOADJUVANT ORGAN-PRESERVING CHEMOTHERAPY FOR ADVANCED LARYNGEAL CARCINOMA [J].
SPAULDING, MB ;
FISCHER, SG ;
WOLF, GT ;
HONG, WK ;
URBA, S ;
ENDICOTT, JW ;
CLOSE, L ;
FISHER, SR ;
TOOHILL, RJ ;
KARP, D ;
MILLER, D ;
CHEUNG, NK ;
WEAVER, A ;
HILLEL, AD ;
SPAULDING, M ;
CHANG, BK ;
DOUGHERTY, B ;
DECONTI, R ;
GAREWAL, H ;
FORASTIERE, A ;
THORNTON, A ;
CALLAWAY, E ;
BEALS, T ;
GREENBERG, H ;
HOLLIMAN, D ;
LYMAN, G ;
SCHAEFER, S ;
COX, J ;
MIDDLETON, R ;
ASKEW, B ;
BRANTLEY, A ;
LEOPOLD, KA ;
WEINBURG, JB ;
LETTINGA, JW ;
HAAS, CD ;
KAPLAN, M ;
BYHARDT, RW ;
CORLEW, MM ;
CAMPBELL, B ;
VAUGHAN, C ;
WILLETT, B ;
WALSH, M ;
URIST, M ;
KIM, R ;
FAUCETT, R ;
PARK, Y ;
OHANIAN, M ;
KAUFMAN, R ;
KISH, J ;
EDELSTEIN, MB .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) :1592-1599
[64]   Toxicity in head and neck cancer: A review of trends and issues [J].
Trotti, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (01) :1-12
[65]   The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy [J].
Van Acker, F ;
Flamen, P ;
Lambin, P ;
Maes, A ;
Kutcher, GJ ;
Weltens, C ;
Hermans, R ;
Baetens, J ;
Dupont, P ;
Rijnders, A ;
Maes, A ;
van den Bogaert, W ;
Mortelmans, L .
NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (02) :225-231
[66]   Beam intensity modulation using tissue compensators or dynamic multileaf collimation ln three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck [J].
van Dieren, EB ;
Nowak, PJCM ;
Wijers, OB ;
de Koste, JRV ;
van der Est, H ;
Binnekamp, DP ;
Heijmen, BJM ;
Levendag, PC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (05) :1299-1309
[67]   Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer [J].
Wasserman, T ;
Mackowiak, JI ;
Brizel, DM ;
Oster, W ;
Zhang, JL ;
Peeples, PJ ;
Sauer, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (04) :1035-1039
[68]   A simplified CT-based definition of the lymph node levels in the node negative neck [J].
Wijers, OB ;
Levendag, PC ;
Tan, T ;
van Dieren, EB ;
de Koste, JV ;
van der Est, H ;
Senan, S ;
Nowak, PJCM .
RADIOTHERAPY AND ONCOLOGY, 1999, 52 (01) :35-42
[69]  
WIJERS OB, 2001, UNPUB HEAD NECK
[70]   ORAL PILOCARPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN XEROSTOMIA [J].
WISEMAN, LR ;
FAULDS, D .
DRUGS, 1995, 49 (01) :143-155